Bladder dysfunction in multiple sclerosis

Neurological Sciences

Volumn 27, Issue SUPPL. 4, 2006, Pages

  Fowler, C J ^a   Kalsi, V ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Bladder; Incontinence; Multiple sclerosis; Treatments

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CANNABINOID; CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; RESINIFERATOXIN; TOLTERODINE; TROSPIUM CHLORIDE;

ARTICLE; BLADDER ASPIRATION; BLADDER CATHETERIZATION; BLADDER DYSFUNCTION; BLADDER RECONSTRUCTION; BLADDER SURGERY; DETRUSOR DYSSYNERGIA; HUMAN; IMPAIRED BLADDER EMPTYING; INDWELLING CATHETER; INTERMITTENT CATHETERIZATION; LONG TERM CARE; MULTIPLE SCLEROSIS; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; QUALITY OF LIFE; SPINAL CORD DISEASE; SYMPTOM;

EID: 33750888031     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0651-6     Document Type: Article

References (15)

1. de Groat W, Kawatani T, Hisamitsu T et al (1990) Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 30:S71-78
2. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167-178
3. Betts CD, D'Mellow MT, Fowler CJ (1993) Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 56:245-250
4. Fowler CJ (1996) Investigation of the neurogenic bladder. J Neurol Neurosurg Psychiatry 60:6-13
5. O'Riordan J, Doherty C, Javed M et al (1995) Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis. J Urol 153:1114-1116
6. Dasgupta P, Haslam C, Goodwin RJ, Fowler CJ (1997) The Queen Square bladder stimulator: A device for assisting emptying of the neurogenic bladder. Br J Urol 80:234-237
7. Fowler CJ, O'Malley KJ (2003) Management and investigation of neurogenic bladder dysfunction. Neurol Pract 74[Suppl IV]:iV27-iv31
8. Hoverd PA, Fowler CJ (1998) Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 65:778-780
9. Brady CM, DasGupta R, Dalton C et al (2004) An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10:425-433
10. Fowler CJ, Beck RO, Gerrard S et al (1994) Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 57:169-173
11. de Seze M,Wiart L, de Seze MP et al (2004) Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: A double-blind, randomized, controlled study. J Urol 171:251-255
12. Schurch B, Stohrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692-697
13. Apostolidis A, Popat R, Yiangou Y et al (2005) Decreased sensory receptors P2x3 and Trpv1 in suburothelial nerve fibers following intradetrusor injections of botulinum 0toxin for human detrusor overactivity. J Urol 174:977-983
14. Harper M, Popat R, Dasgupta R et al (2003) A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92:325-326
15. Popat R, Apostolidis A, Kalsi V et al (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174:984-988